Natural isothiocyanates: genotoxic potential versus chemoprevention

Carmela Fimognari1, Eleonora Turrini1, Lorenzo Ferruzzi1

  • 1Department of Pharmacology, University of Bologna, via Irnerio 48, 40126 Bologna, Italy.

Mutation Research
|December 20, 2011
PubMed

Insights

Isothiocyanates from cruciferous vegetables offer chemopreventive benefits against chronic diseases by modulating protein and antioxidant pathways. However, their genotoxicity warrants careful consideration, especially in supplements.

Area of Science:

  • Nutritional Biochemistry
  • Molecular Toxicology
  • Chemoprevention Research

Background:

  • Isothiocyanates (ITCs) are bioactive compounds found in cruciferous vegetables with demonstrated chemopreventive properties.
  • ITCs exert protective effects against chronic-degenerative diseases like cancer, cardiovascular diseases, neurodegeneration, and diabetes.
  • Key mechanisms involve protein modification, activation of the nuclear factor-erythroid-2-related factor 2 (NRF2) system, and inhibition of chronic inflammation.

Purpose of the Study:

  • To review the chemopreventive activities and potential toxicological risks of isothiocyanates.
  • To elucidate the molecular mechanisms underlying both the beneficial and potentially harmful effects of ITCs.
  • To assess the safety of increased consumption of ITCs through dietary supplements and functional foods.

Main Methods:

  • Literature review of studies on isothiocyanate biological activities and toxicity.
  • Analysis of molecular mechanisms including protein adduct formation, NRF2 pathway activation, and inflammatory mediator inhibition.
  • Evaluation of genotoxicity data and comparison with dietary intake levels.

Main Results:

  • Isothiocyanates demonstrate broad chemopreventive potential through antioxidant and anti-inflammatory actions.
  • Electrophilic reactivity of ITCs leads to protein modification and potential DNA adduct formation, raising genotoxicity concerns.
  • Dietary intake levels are significantly lower than those causing toxicity in studies, suggesting low risk from food sources.

Conclusions:

  • While ITCs offer significant health benefits, their genotoxic potential requires careful evaluation, particularly at elevated concentrations found in supplements.
  • The dose-response relationship for genotoxic compounds lacks a threshold, emphasizing the need for caution.
  • Further toxicological assessment is crucial before recommending increased ITC consumption or clinical applications.

Related Concept Videos

Mutagenicity and Carcinogenicity01:25

Mutagenicity and Carcinogenicity

Mutagenicity and carcinogenicity refer to the ability of drugs to cause genetic defects and induce cancer, respectively. The International Agency for Research on Cancer (IARC) classifies agents into four groups based on their carcinogenic potential. Group 1 agents are known human carcinogens; group 2A agents are probably carcinogenic to humans; group 3 agents lack data to support their role in carcinogenesis; and group 4 includes agents for which data support that they are not likely to be...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
Bioactivation and Tissue Toxicity01:25

Bioactivation and Tissue Toxicity

Bioactivation is a metabolic process that transforms less reactive substances into highly reactive metabolites, initiating tissue toxicity. This transformation can lead to various toxic effects, including carcinogenesis and teratogenesis. Reactive metabolites are classified into two main types: electrophiles and free radicals.Electrophiles are electron-deficient species and are produced primarily by the enzyme cytochrome P-450 during the metabolism of compounds containing carbon, nitrogen, or...
Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase01:11

Pharmacogenetics of Drug Targets: β₂-Adrenergic Receptors, Apo E, Thymidylate Synthase

Genetic polymorphisms in drug targets have emerged as critical determinants of interindividual variability in drug response and toxicity. Pharmacogenomic investigations increasingly focus on identifying these variations to personalize and optimize therapeutic interventions. A drug target may be a receptor, enzyme, or signaling protein involved in pharmacologic responses or disease-related pathways. While early pharmacogenetic studies focused primarily on drug metabolism, current research...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Cancer-Critical Genes II: Tumor Suppressor Genes01:05

Cancer-Critical Genes II: Tumor Suppressor Genes

Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...